An antigen test in cassette format for the qualitative detection of Chlamydia antigen in endocervical swab or urine specimens, read at 5 minutes. For professional in vitro diagnostic use.
The inSTIcheck™ chlamydia rapid test from First Diagnostic™ Corporation is a rapid chromatographic immunoassay for the qualitative detection of Chlamydia trachomatis directly from endocervical swab or urine specimens. It is an antigen test and does not detect antibodies in blood.
It is for professional in vitro diagnostic use, to aid in the diagnosis of Chlamydia infection. Results must be interpreted by a clinician with other clinical and laboratory findings. See the full STI rapid tests range in our rapid tests catalog.
| Brand | inSTIcheck™ |
|---|---|
| Catalog number | 85226400030 |
| Format | Lateral flow cassette (rapid chromatographic immunoassay), qualitative |
| Target | Chlamydia antigen |
| Specimen | Endocervical swab or urine. The insert also describes male urethral swab collection. |
| Sample volume | 4 drops of extracted solution into the sample well (S) |
| Time to result | Read at 5 minutes |
| Read window | Do not read after 15 minutes |
| Kit sizes | 20, 40 or 100 tests |
| Kit contents (as listed in the insert) | Individually pouched test devices and pipettes; Buffer A; Buffer B (the Reagents A and B of the procedure); sterile urethral swabs; positive control; negative control; package insert. The insert’s quality control section says control standards are not supplied, so confirm at quotation. |
| Required but not provided | Centrifuge tube (urine specimens only) |
| Storage | 2–30 °C (see kit label), in the sealed pouch. Do not freeze. |
| Intended user | Healthcare professionals |
| Regulatory | CE marked (as shown on the product insert) |
| Insert document | inSTIcheck™ Chlamydia package insert, product code 85226400030 |
The cassette is a qualitative lateral flow immunoassay based on antigen capture. Antigen is extracted from the specimen with two reagents, and the extracted solution reacts with particles coated with an antibody to Chlamydia.
The mixture migrates along the membrane to the test line, which is coated with an antibody specific to the Chlamydia antigen; a colored line there indicates a positive result. A colored control line shows that the proper volume of specimen was added and that membrane wicking occurred. Our guide to lateral flow tests explains the principle.
Swab procedure, summarized from the insert.
This summary does not replace the instructions for use supplied with the kit.
Performance characteristics against the comparator method are given in the product insert, available on the product inserts page.
The insert also lists organisms that tested negative with the device, including Neisseria gonorrhoeae, Neisseria meningitidis, Gardnerella vaginalis, Candida albicans and Escherichia coli.
The package insert contains the full instructions for use, quality control guidance and performance characteristics.
An antigen test. It detects Chlamydia antigen extracted from an endocervical swab or urine specimen. It does not detect antibodies and is not run on blood.
The insert lists kits of 20, 40 and 100 tests. Store in the sealed pouch at 2–30 °C (see kit label), away from sunlight, moisture and heat. Do not freeze.
Each cassette has a built-in control line. The insert recommends running positive and negative controls as good laboratory practice; ask us whether external controls are supplied with the kit you order.
Email sales@firstdiagnostic.com for a quotation, or complete the distributor application. First Diagnostic supplies customers outside the United States.
First Diagnostic brands and distributes lateral flow rapid tests made by established IVD manufacturers. Tell us your market, kit size and volume, and we will reply with pricing and documentation.
Source: inSTIcheck™ Chlamydia package insert, product code 85226400030 · Last reviewed: October 2026 · First Diagnostic™ editorial team
Regulatory status: Products shown on this website are for professional in vitro diagnostic use. They are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale in the United States. Product availability and regulatory status vary by country; contact us for the status in your market.